반응식
[CH2:1]([N:3]1[CH2:8][CH2:7][N:6]([C:9]2[CH:15]=[CH:14][C:12]([NH2:13])=[CH:11][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2].C(N1CCN(C2C=C(N[C:31]([C:33]3[C:34]4[N:35]=[CH:36][CH:37]=[N:38][C:39]=4[C:40]([C:43]4[CH:48]=[C:47]([O:49][CH3:50])[CH:46]=[CH:45][C:44]=4[Cl:51])=[CH:41][CH:42]=3)=[O:32])C=CC=2)CC1)C>>[CH2:1]([N:3]1[CH2:4][CH2:5][N:6]([C:9]2[CH:15]=[CH:14][C:12]([NH:13][C:31]([C:33]3[C:34]4[N:35]=[CH:36][CH:37]=[N:38][C:39]=4[C:40]([C:43]4[CH:48]=[C:47]([O:49][CH3:50])[CH:46]=[CH:45][C:44]=4[Cl:51])=[CH:41][CH:42]=3)=[O:32])=[CH:11][CH:10]=2)[CH2:7][CH2:8]1)[CH3:2]참가 물질
3
실험 절차
The title compound was prepared in analogy to the procedure described in Step 14.1 but using 4-(4-ethylpiperazin-1-yl)-aniline (Step 1.9) and 8-(2-chloro-5-methoxy-phenyl)quinoxaline-5-carboxylic acid (Example 63). Title compound: ESI-MS: 502.1 [M]+; tR=3.50 min (System 3).
후처리
- customThe title compound was prepared in analogy to the procedure
출처 및 근거
- ORD 기록
- ord-067e088f15f4434d9a60c46db78b0ff6
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08536175B2
연결된 노트
불러오는 중…